MRSA is an especially ubiquitous pathogen in patients with CF. Risk factors must be evaluated, and strict infection control practices must be in place to prevent MRSA, minimize transmission and optimize CF patient outcomes.
Our multidisciplinary team treats local patients as well as CF patients from all over the world with difficult-to-treat infections.
Recent therapeutic advances that target the basic genetic defect in cystic fibrosis is proving to be a game changer in treating adult CF.
The director of Cleveland Clinic Children’s cystic fibrosis program opines on the merits and pitfalls of newborn screening, when to refer and the benefits of teaming with adult-care specialists.